Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TERRY J ROSEN Insider Profile
4 Followers
TERRY J ROSEN, CEO, Director at Arcus Biosciences, holds 3.95M shares in Arcus Biosciences (Ticker: RCUS), holds ― shares in IDEAYA Biosciences (Ticker: IDYA).
Profitable Transactions
6 out of 12 Profitable Transactions
Average Return
+33.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that TERRY J ROSEN holds in companies
Most Profitable Insider Trade
The most profitable trade made by TERRY J ROSEN
TERRY J ROSEN's Trading History
Arcus Biosciences
Jun 18, 2024
CEO, Director
Uninformative Sell
215.01K
$62.40M
IDEAYA Biosciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see TERRY J ROSEN's performance on stock
You May Also Like
TERRY J ROSEN insider profile FAQ
What is the percentage of profitable transactions made by TERRY J ROSEN?
The percentage of profitable transactions made by TERRY J ROSEN is 50%.
What is the average return per transaction made by TERRY J ROSEN?
The average return per transaction made by TERRY J ROSEN is 33.90%.
What stocks does TERRY J ROSEN hold?
TERRY J ROSEN holds: RCUS, IDYA stocks.
What was TERRY J ROSEN’s latest transaction?
TERRY J ROSEN latest transaction was an Uninformative Sell of $215.01K.
What was TERRY J ROSEN's most profitable transaction?
TERRY J ROSEN’s most profitable transaction was an Informative Buy of RCUS stock on June 5, 2019. The return on the trade was 262.60%.
What is TERRY J ROSEN's role in Arcus Biosciences?
TERRY J ROSEN's role in Arcus Biosciences is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.